SCHEMBL9418

SCHEMBL9418

Cc1noc(-c2cc(C3(C(=O)O)CC3)ccc2-c2ccccc2)c1CN1CC(c2ccccc2)OC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.39
PTGDR2 Q9Y5Y4 2/20 0.36
CYP2C9 P11712 4/20 0.36
ABCC3 O15438 1/20 0.36
ABCC4 O15439 1/20 0.36
ABCB11 O95342 1/20 0.36
CYP2C8 P10632 1/20 0.36
ABCB4 P21439 1/20 0.36
LPAR1 Q92633 1/20 0.36
ABCC2 Q92887 1/20 0.36
SLCO1B3 Q9NPD5 1/20 0.36
SLCO1B1 Q9Y6L6 1/20 0.36
CYP3A4 P08684 4/20 0.35
APP P05067 4/20 0.35
CYP2C19 P33261 4/20 0.35
CYP2D6 P10635 2/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
CETP P11597 2/20 0.34
AKR1C3 P42330 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9419 0.92 CYP2C9 (0.40) FADS1PTGDR2CYP2C9ABCC3ABCC4
SCHEMBL3509 0.87 LPAR1 (0.45) FADS1PTGDR2CYP2C9ABCC3ABCC4
SCHEMBL9915 0.83 SCD5 (0.42) PTGDR2CYP2C9ABCC3ABCC4ABCB11
SCHEMBL9916 0.83 SCD5 (0.42) PTGDR2CYP2C9ABCC3ABCC4ABCB11
SCHEMBL4772 0.80 ABCC3 (0.40) FADS1CYP2C9ABCC3ABCC4ABCB11
SCHEMBL10037 0.78 HDAC1 (0.40) PTGDR2CYP2C9ABCC3ABCC4ABCB11
SCHEMBL10038 0.78 HDAC1 (0.40) PTGDR2CYP2C9ABCC3ABCC4ABCB11
Bicarbonate SCHEMBL18167234 0.75 FADS1 (0.41) FADS1PTGDR2HCRTR1HCRTR2HDAC1
SCHEMBL11688 0.75 SIGMAR1 (0.40)
SCHEMBL9917 0.74 SCD5 (0.43) PTGDR2CYP2C9ABCC3ABCC4ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed